Abstract
The last 20 years of the twentieth century witnessed a dramatic increase in research aimed at determining the mechanisms that regulate feeding behavior. Researchers, prompted by the alarming increase in the prevalence of obesity have identified many brain neuropeptides, especially in the hypothalamus that promote or inhibit food intake. How the complex interactions of these peptides leads to obesity has been clarified somewhat; unfortunately, this has not led to major advances in anti-obesity drug discovery. Continued effort during the first years of the new millennium has led to the discovery of new peptides mainly through inverse pharmacology techniques. In this article, we update information on obestatin, a closely related companion of ghrelin, on neuropeptide S, neuropeptide W, and others. These peptides use both classical and independent regulatory pathways to modulate feeding but often have additional biological activities. Strong arguments support a role in feeding regulation for some peptides. For others, this role remains controversial and further research is needed to clarify their exact effects.
Keywords: G-protein coupled receptor, Rfamide, neuromedins, 26Rfa, VGF, QRFP, hypothalamus, obesity
Central Nervous System Agents in Medicinal Chemistry
Title: Neuropeptides B, S and W, Obestatin/Ghrelin-Associated Peptide, and Others: Really New Feeding Regulatory Peptides?
Volume: 8 Issue: 1
Author(s): Bernard Beck, Carine Pourie and Jean-Louis Gueant
Affiliation:
Keywords: G-protein coupled receptor, Rfamide, neuromedins, 26Rfa, VGF, QRFP, hypothalamus, obesity
Abstract: The last 20 years of the twentieth century witnessed a dramatic increase in research aimed at determining the mechanisms that regulate feeding behavior. Researchers, prompted by the alarming increase in the prevalence of obesity have identified many brain neuropeptides, especially in the hypothalamus that promote or inhibit food intake. How the complex interactions of these peptides leads to obesity has been clarified somewhat; unfortunately, this has not led to major advances in anti-obesity drug discovery. Continued effort during the first years of the new millennium has led to the discovery of new peptides mainly through inverse pharmacology techniques. In this article, we update information on obestatin, a closely related companion of ghrelin, on neuropeptide S, neuropeptide W, and others. These peptides use both classical and independent regulatory pathways to modulate feeding but often have additional biological activities. Strong arguments support a role in feeding regulation for some peptides. For others, this role remains controversial and further research is needed to clarify their exact effects.
Export Options
About this article
Cite this article as:
Beck Bernard, Pourie Carine and Gueant Jean-Louis, Neuropeptides B, S and W, Obestatin/Ghrelin-Associated Peptide, and Others: Really New Feeding Regulatory Peptides?, Central Nervous System Agents in Medicinal Chemistry 2008; 8 (1) . https://dx.doi.org/10.2174/187152408783790640
DOI https://dx.doi.org/10.2174/187152408783790640 |
Print ISSN 1871-5249 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6166 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Stress, Depression and Antidepressant Treatment Options in Patients Suffering from Multiple Sclerosis
Current Pharmaceutical Design Neurotransmission Alterations in Central Cardiovascular Control in Experimental Hypertension
Current Hypertension Reviews Microsomal Prostaglandin E Synthase: A Key Enzyme in PGE2 Biosynthesis and Inflammation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Novel Drug Therapies for Fertility Preservation in Men Undergoing Chemotherapy: Clinical Relevance of Protector Agents
Current Medicinal Chemistry Leptin and Inflammation
Current Immunology Reviews (Discontinued) Innovative Treatment Approach for Cancer-Related Cachexia
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Mitochondrial Functionality and Chemical Compound Action on Sperm Function
Current Medicinal Chemistry Melanin-Concentrating Hormone as a Metabolic and Cognitive Regulatory Factor
Current Medicinal Chemistry - Central Nervous System Agents Role of Gut Microbiota in Obesity, Type 2 Diabetes and Alzheimer’s Disease
CNS & Neurological Disorders - Drug Targets Preface[Hot Topic: Medicinal Strategies in the Treatment of Obesity (Guest Editor: Akio Inui)]
Current Medicinal Chemistry - Central Nervous System Agents Chemistry and Pharmacology of Angiotensin-Converting Enzyme Inhibitors
Current Pharmaceutical Design Delineating Somatostatins Neuronal Actions
Current Drug Targets - CNS & Neurological Disorders Carnosine and Kidney Diseases: What We Currently Know?
Current Medicinal Chemistry Spatiotemporal Modulation of Central Neural Pathway Underlying Acupuncture Action: A Systematic Review
Current Medical Imaging Systematic Review and Meta-analysis of Pharmacological Interventions for Weight Gain from Antipsychotics and Mood Stabilizers
Current Psychiatry Reviews Opiates as Antidepressants
Current Pharmaceutical Design The Effects of Weightlessness on the Human Organism and Mammalian Cells
Current Molecular Medicine Interventions Against Sarcopenia in Older Persons
Current Pharmaceutical Design Effects of Novel Monoamine Oxidases and Cholinesterases Targeting Compounds on Brain Neurotransmitters and Behavior in Rat Model of Vascular Dementia
Current Pharmaceutical Design Sex Steroid Hormones, Cardiovascular Diseases and The Metabolic Syndrome
Cardiovascular & Hematological Agents in Medicinal Chemistry